Movatterモバイル変換


[0]ホーム

URL:


Journal Logo

Email to Colleague

Colleague's E-mail is Invalid

Your Name:
Colleague's Email:
Separate multiple e-mails with a (;).
Message:

Your message has been successfully sent to your colleague.



Some error has occurred while processing your request. Please try after some time.

Export to

Anesthetic Pharmacology: Research Reports

The Counteraction of Opioid-Induced Ventilatory Depression by the Serotonin 1A-Agonist 8-OH-DPAT Does Not Antagonize Antinociception in RatsIn Situ andIn Vivo

Guenther, Ulf MD*; Manzke, Till PhD; Wrigge, Hermann PhD*; Dutschmann, Matthias PhD; Zinserling, Joerg PhD*; Putensen, Christian PhD*; Hoeft, Andreas PhD*

Author Information

From the *Clinic of Anesthesiology and Intensive Care Medicine, University of Bonn, Sigmund-Freud-Strasse 25, Bonn, Germany; and †DFG Research Center Molecular Physiology of the Brain (CMPB), Goettingen, Humboldtallee 23, Goettingen, Germany.

Accepted for publication December 10, 2008.

Ulf Guenther and Till Manzke contributed equally to this work.

Supported by Departmental Funds.

Address correspondence and reprints request to Ulf Guenther, MD, DESA, EDIC; Clinic of Anesthesiology and Intensive Care, University Hospital of Bonn, Sigmund-Freud-St. 25, D-53105 Bonn, Germany. Address e-mail to[email protected].

Anesthesia & Analgesia108(4):p 1169-1176, April 2009. |DOI:10.1213/ane.0b013e318198f828

BACKGROUND: 

Spontaneous breathing during mechanical ventilation is gaining increasing importance during intensive care but is depressed by narcotics, such as opioids. Serotonin 1A-receptor (5-HT1A-R) agonists have been shown to antagonize opioid-induced ventilatory depression, but both enhancement and attenuation of nociceptive reflexes have been found with different experimental models. To clarify contradictory findings, we simultaneously determined dose-response functions of the standard 5-HT1A-R-agonist 8-OH-DPAT and two different opioids for spontaneous ventilation and nociception. Two hypotheses were tested: 1) 8-OH-DPAT at a dose to stimulate spontaneous breathing does not activate nociceptive reflexes. 2) 8-OH-DPAT does not diminish opioid-induced antinociception.

METHODS: 

(A) A dose-response relationship of 8-OH-DPAT, spontaneous phrenic nerve activity and a nociceptive C-fiber reflex (CFR) were established simultaneously in anin situ perfused, nonanesthetized, rat brainstem-spinal cord preparation. (B) Fentanyl was administeredin situ to investigate the interaction with 8-OH-DPAT on phrenic nerve activity and nociceptive CFR. Additional experiments involved the selective 5-HT1A-R-antagonist WAY 100 635 to exclude effects of receptors other than 5-HT1A-R. (C) The effects of 8-OH-DPAT on spontaneous ventilation and nociceptive tail-flick reflex with and without morphine were verified inin vivo anesthetized rats.

RESULTS: 

Low-dose 8-OH-DPAT (0.001 and 0.01 μMin situ, 0.1 μg/kgin vivo) enhanced nociceptive reflexes but did not activate spontaneous ventilation. On the contrary, high doses of 8-OH-DPAT (1 μMin situ and 10–100 μg/kgin vivo) stimulated ventilation, whereas nociceptive CFR amplitudein situ returned to baseline and tail-flick reflex was depressedin vivo. Opioid-induced ventilatory depression was antagonized by 8-OH-DPAT (1 μMin situ, and 10 μg/kgin vivo), whereas antinociception sustained. Selective 5-HT1A-R-antagonist WAY 100 635 (1 μM) prevented the effects of 8-OH-DPATin situ.

CONCLUSION: 

5-HT1A-R-agonist 8-OH-DPAT activates spontaneous breathing without diminishing opioid-induced antinociception in rats.

© 2009 International Anesthesia Research Society

You can read the full text of this article if you:

Log InAccess through Ovid
Email to Colleague

Colleague's E-mail is Invalid

Your Name:
Colleague's Email:
Separate multiple e-mails with a (;).
Message:

Your message has been successfully sent to your colleague.



Some error has occurred while processing your request. Please try after some time.


[8]ページ先頭

©2009-2026 Movatter.jp